Company profile: Medsenic
1.1 - Company Overview
Company description
- Provider of drug development and manufacturing focused on drugs for the treatment of autoimmune diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medsenic
Ampio Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies targeting inflammatory conditions, including OA-201, a small molecule formulation explored as a potential treatment for osteoarthritis of the knee and other joints.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampio Pharmaceuticals company profile →
Phenex Pharmaceuticals
HQ: Germany
Website
- Description: Provider of drug discovery and development focused on novel pharmaceuticals, leveraging small-molecule expertise. Privately held, founded in 2002, with Biology and Chemistry laboratories and offices in the Biotech Cluster Rhine-Neckar, primarily in Heidelberg and partly in Ludwigshafen.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phenex Pharmaceuticals company profile →
DBV Technologies
HQ: France
Website
- Description: Provider of investigational epicutaneous immunotherapy products for food allergies and other immunological disorders via the Viaskin technology platform, including Viaskin Peanut, a patch delivering small amounts of peanut protein to the skin. Also developing Viaskin-based approaches for other food allergies, an investigational diagnostic for non-IgE-mediated milk allergy, and non-invasive vaccine delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DBV Technologies company profile →
Taligen Therapeutics
HQ: United States
Website
- Description: Provider of novel protein therapeutics that modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases, with lead candidates including monoclonal antibodies and recombinant fusion proteins targeting key factors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Taligen Therapeutics company profile →
Kynos Therapeutics
HQ: United Kingdom
Website
- Description: Provider of small-molecule KMO inhibitor therapeutics for inflammation, immunity, and metabolism. Offers KNS366, a Phase I KMO inhibitor designed to reduce elevated 3-HK to prevent tissue damage and immune dysregulation during inflammation, and a portfolio targeting acute and chronic inflammatory disorders, including acute kidney injury and acute pancreatitis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kynos Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medsenic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medsenic
2.2 - Growth funds investing in similar companies to Medsenic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medsenic
4.2 - Public trading comparable groups for Medsenic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →